EBIT grew by 12% compared with the first nine months of 2011, increasing the EBIT margin to 24.6%. The expectations for full-year 2012 EBIT growth, EBIT margin and net profit growth are maintained, as is the expectation for free cash flow.
The expectation for organic sales growth is adjusted within the previously announced range to 4%. Sales growth is now expected at 3% in local currencies and 7% in DKK.
Source: Novozymes
© FoodBev Media Ltd 2024